Adrenal gland tumor

  • Jan 21, 2019 www.dotmed.com
    FDA clears MIM SurePlan molecular radiotherapy software – DOTmed.com
    Read More
  • Jan 21, 2019 www.fredericksburg.com
    Virginia doctor has a side operation: Selling coffee to help pay for health care overseas – Fredericksburg.com
    Read More
  • Progenics Pharmaceuticals (PGNX) Downgraded by Zacks Investment Research to Hold – Fairfield Current
    Read More
  • Jan 17, 2019 whatsonthorold.com
    Progenics Pharmaceuticals Inc (NASDAQ:PGNX): Institutional Investors Aren’t Crazy About It | Thorold News – Thorold News
    Read More
  • -$0.08 Earnings Per Share Expected for Progenics Pharmaceuticals, Inc. (PGNX) This Quarter – Fairfield Current
    Read More
  • Prudential Financial Inc. Acquires 13,790 Shares of Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) – Fairfield Current
    Read More
  • Pacer Advisors Inc. Invests $102,000 in Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) Stock – Fairfield Current
    Read More
  • Jan 07, 2019 www.digitaljournal.com
    Neuroendocrine Tumors Market: Growing Prevalence of Neuroendocrine Tumors Is Expected to Drive the Growth of Market – Press Release – Digital Journal
    Read More
  • Jan 07, 2019 www.equities.com
    Progenics Pharmaceuticals Inc. (PGNX) Soars 8.05% on January 07 – Equities.com
    Read More

Connect. Empower. Inspire.